Literature DB >> 18190829

Continuous bladder irrigation prevents hemorrhagic cystitis after allogeneic hematopoietic cell transplantation.

Molouk Hadjibabaie1, Kamran Alimoghaddam, Ahmad Reza Shamshiri, Masoud Iravani, Babak Bahar, Asadollah Mousavi, Mohammad Jahani, Ali Khodabandeh, Yasha Anvari, Kheirollah Gholami, Ardeshir Ghavamzadeh.   

Abstract

Hemorrhagic cystitis is 1 of the most troublesome complications of hematopoietic cell transplantation conditioning regimens. We conducted a nonrandomized controlled clinical study to investigate the role of continuous bladder irrigation in addition to mesna, hydration, and alkalization in the prevention of hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. A total of 80 eligible patients entered the study. From May 2006, 40 patients who underwent allogeneic hematopoietic cell transplantation received continuous bladder irrigation in addition to the common protocol. A historical control group of 40 consecutive patients with same inclusion criteria who did not receive bladder irrigation was enrolled from before May 2006. Hemorrhagic cystitis occurred in 50% of patients in the no bladder irrigation group versus 32% in bladder irrigation group (P = 0.11). The mean duration of hemorrhagic cystitis was significantly reduced in the bladder irrigation group (10 vs. 18 days; P = 0.02). Duration of hospitalization was significantly shorter in the bladder irrigation group (30.2 vs. 39.6; P < 0.001). Late-onset hemorrhagic cystitis that occurred beyond 4 weeks after allo-hemorrhagic cystitis happened more significantly in the no bladder irrigation group (P = 0.001). High-grade hemorrhagic cystitis was more frequently associated with high-grade graft-versus-host disease within 30 days after transplant (P = 0.06). In general, continuous bladder irrigation added to mesna, hydration, and alkalization regimens was well tolerated, decreased the complications of hemorrhagic cystitis, and may be useful in hematopoietic cell transplantation patients. However, more investigations with randomized controlled clinical trials with more patients are needed.

Entities:  

Mesh:

Year:  2007        PMID: 18190829     DOI: 10.1016/j.urolonc.2006.12.015

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  9 in total

Review 1.  Evidence-Based Practice Recommendations for Hydration in Children and Adolescents With Cancer Receiving Intravenous Cyclophosphamide.

Authors:  Deborah Robinson; Ginny Schulz; Rachel Langley; Kevin Donze; Kari Winchester; Cheryl Rodgers
Journal:  J Pediatr Oncol Nurs       Date:  2014-05-05       Impact factor: 1.636

2.  Canadian Urological Association Best Practice Report: Pediatric hemorrhagic cystitis.

Authors:  Jessica H Hannick; Martin A Koyle
Journal:  Can Urol Assoc J       Date:  2019-11       Impact factor: 1.862

3.  The use of hyperbaric oxygen therapy in the treatment of hemorrhagic cystitis after allogeneic stem cell transplantation from an unrelated donor.

Authors:  Donata Urbaniak-Kujda; Katarzyna Kapelko-Słowik; Monika Biernat; Jarosław Dybko; Magdalena Laszkowska; Kazimierz Kuliczkowski
Journal:  Int J Hematol       Date:  2015-06-30       Impact factor: 2.490

4.  Successful treatment of BK virus-associated severe hemorrhagic cystitis with bilateral single-J ureteral stenting.

Authors:  Akira Fujita; Kohei Kobatake; Takafumi Fukushima; Kenshiro Takemoto; Syunsuke Miyamoto; Hiroyuki Kitano; Kenichiro Ikeda; Keisuke Goto; Keisuke Hieda; Shuhei Karakawa; Tetsutaro Hayashi; Jun Teishima; Nobuyuki Hinata
Journal:  IJU Case Rep       Date:  2022-04-26

5.  Hemorrhagic cystitis: A challenge to the urologist.

Authors:  R Manikandan; Santosh Kumar; Lalgudi N Dorairajan
Journal:  Indian J Urol       Date:  2010-04

Review 6.  Chemical- and radiation-induced haemorrhagic cystitis: current treatments and challenges.

Authors:  Heather Payne; Andrew Adamson; Amit Bahl; Jonathan Borwell; David Dodds; Catherine Heath; Robert Huddart; Rhona McMenemin; Prashant Patel; John L Peters; Andrew Thompson
Journal:  BJU Int       Date:  2013-11       Impact factor: 5.588

7.  Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia.

Authors:  Eugenio Galli; Federica Sorà; Luca Di Gianfrancesco; Sabrina Giammarco; Elisabetta Metafuni; Maria Assunta Limongiello; Idanna Innocenti; Francesco Autore; Luca Laurenti; Patrizia Chiusolo; Andrea Bacigalupo; Simona Sica
Journal:  Support Care Cancer       Date:  2022-02-18       Impact factor: 3.359

Review 8.  Haemorrhagic cystitis in haematopoietic stem cell transplantation (HSCT): a prospective observational study of incidence and management in HSCT centres within the GITMO network (Gruppo Italiano Trapianto Midollo Osseo).

Authors:  G Gargiulo; L Orlando; F Alberani; G Crabu; A Di Maio; L Duranti; A Errico; S Liptrott; R Pitrone; S Santarone; C Soliman; A Trunfio; C Selleri; B Bruno; S Mammoliti; F Pane
Journal:  Ecancermedicalscience       Date:  2014-04-10

9.  Nursing Management of Haemorrhagic Cystitis in Patients Undergoing Haematopoietic Stem Cell Transplantation: a Multicentre Italian Survey.

Authors:  Chiara Visintini; Margherita Venturini; Stefano Botti; Gianpaolo Gargiulo; Alvisa Palese
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-09-01       Impact factor: 2.576

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.